Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Kolon TissueGene (950160 KS)
Watchlist
16
Analysis
Health Care
•
United States
Kolon TissueGene, Inc. operates as a biopharmaceutical company. The Company develops novel advanced orthopedic disorders cell therapies, novel cell and gene therapies drugs, and other related products. Kolon TissueGene offers services worldwide.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
19 Feb 2018 10:27
Korean IPOs - Evidence-Based Analysis & The Whiplash Effect
In this report, we provide evidence-based analysis of using key criteria such as the IPO price determined at high/low end of the IPO price range...
Douglas Kim
Follow
370 Views
Share
bullish
•
Thematic (Sector/Industry)
•
25 Nov 2017 21:53
Summary of KOSDAQ 150 December Reshuffle & Rebalancing
It was officially announced that a total of 13 stocks would be newly added to KOSDAQ 150 in the upcoming periodical reshuffle, whereas the same...
Sanghyun Park
Follow
746 Views
Share
bullish
•
Thematic (Sector/Industry)
•
16 Nov 2017 22:57
KOSDAQ's Bullish Run - Main Drivers & Stocks to Pick
KOSDAQ is getting really hot. Over the past three months, KOSDAQ index climbed 22.89% by 145.31 points from 642.11 on Aug 17 to 780.22 today on Nov...
Sanghyun Park
Follow
799 Views
Share
bearish
•
Quantitative Analysis
•
13 Aug 2025 07:05
KRX Short Interest Weekly (Aug 8th): Silicon2, NAVER, LG Chem, KakaoBank, POSCO FUTURE M
We analyzed KRX short interest report for the past week and highlighted short interest changes in Silicon2, NAVER, LG Chem, KakaoBank, POSCO FUTURE M.
Ke Yan, CFA, FRM
Follow
367 Views
Share
bullish
•
Kolon Mobility Group
•
11 Aug 2025 12:06
Kolon Mobility (450140 KS)'s Delisting Offer
Trading tight to the cash terms at a 0.7%/9.8% and 0.7%/8.6% gross/annual spread for the common & preferred. The scrip terms for both are well out...
David Blennerhassett
Follow
363 Views
Share
1
2
3
4
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x